Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery

Fraser C. Goldie, Rachael L. Fulton, Jesse Dawson, Erich Bluhmki, Kennedy R. Lees, Andrei Alexandrov, P. W. Bath, E. Bluhmki, L. Claesson, J. Curram, S. M. Davis, G. Donnan, H. C. Diener, M. Fisher, B. Gregson, J. Grotta, W. Hacke, M. G. Hennerici, M. Hommel, M. Kaste & 9 others P. Lyden, J. Marler, K. Muir, R. Sacco, A. Shuaib, P. Teal, N. G. Wahlgren, S. Warach, C. Weimar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Clinical trials for acute ischemic stroke treatment require large numbers of participants and are expensive to conduct. Methods that enhance statistical power are therefore desirable. Aims: We explored whether this can be achieved by a measure incorporating both early and late measures of outcome (e.g. seven-day NIH Stroke Scale combined with 90-day modified Rankin scale). Methods: We analyzed sensitivity to treatment effect, using proportional odds logistic regression for ordinal scales and generalized estimating equation method for global outcomes, with all analyses adjusted for baseline severity and age. We ran simulations to assess relations between sample size and power for ordinal scales and corresponding global outcomes. We used R version 2·12·1 (R Development Core Team. R Foundation for Statistical Computing, Vienna, Austria) for simulations and SAS 9·2 (SAS Institute Inc., Cary, NC, USA) for all other analyses. Results: Each scale considered for combination was sensitive to treatment effect in isolation. The mRS90 and NIHSS90 had adjusted odds ratio of 1·56 and 1·62, respectively. Adjusted odds ratio for global outcomes of the combination of mRS90 with NIHSS7 and NIHSS90 with NIHSS7 were 1·69 and 1·73, respectively. The smallest sample sizes required to generate statistical power ≥80% for mRS90, NIHSS7, and global outcomes of mRS90 and NIHSS7 combined and NIHSS90 and NIHSS7 combined were 500, 490, 400, and 380, respectively. Discussion: When data concerning both early and late outcomes are combined into a global measure, there is increased sensitivity to treatment effect compared with solitary ordinal scales. This delivers a 20% reduction in required sample size at 80% power. Combining early with late outcomes merits further consideration.

Original languageEnglish (US)
Pages (from-to)755-758
Number of pages4
JournalInternational Journal of Stroke
Volume9
Issue number6
DOIs
StatePublished - Aug 1 2014

Fingerprint

Sample Size
Stroke
Mathematical Computing
Odds Ratio
Austria
Logistic Models
Outcome Assessment (Health Care)
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Neurology

Cite this

Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. / Goldie, Fraser C.; Fulton, Rachael L.; Dawson, Jesse; Bluhmki, Erich; Lees, Kennedy R.; Alexandrov, Andrei; Bath, P. W.; Bluhmki, E.; Claesson, L.; Curram, J.; Davis, S. M.; Donnan, G.; Diener, H. C.; Fisher, M.; Gregson, B.; Grotta, J.; Hacke, W.; Hennerici, M. G.; Hommel, M.; Kaste, M.; Lyden, P.; Marler, J.; Muir, K.; Sacco, R.; Shuaib, A.; Teal, P.; Wahlgren, N. G.; Warach, S.; Weimar, C.

In: International Journal of Stroke, Vol. 9, No. 6, 01.08.2014, p. 755-758.

Research output: Contribution to journalArticle

Goldie, FC, Fulton, RL, Dawson, J, Bluhmki, E, Lees, KR, Alexandrov, A, Bath, PW, Bluhmki, E, Claesson, L, Curram, J, Davis, SM, Donnan, G, Diener, HC, Fisher, M, Gregson, B, Grotta, J, Hacke, W, Hennerici, MG, Hommel, M, Kaste, M, Lyden, P, Marler, J, Muir, K, Sacco, R, Shuaib, A, Teal, P, Wahlgren, NG, Warach, S & Weimar, C 2014, 'Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery', International Journal of Stroke, vol. 9, no. 6, pp. 755-758. https://doi.org/10.1111/ijs.12131
Goldie, Fraser C. ; Fulton, Rachael L. ; Dawson, Jesse ; Bluhmki, Erich ; Lees, Kennedy R. ; Alexandrov, Andrei ; Bath, P. W. ; Bluhmki, E. ; Claesson, L. ; Curram, J. ; Davis, S. M. ; Donnan, G. ; Diener, H. C. ; Fisher, M. ; Gregson, B. ; Grotta, J. ; Hacke, W. ; Hennerici, M. G. ; Hommel, M. ; Kaste, M. ; Lyden, P. ; Marler, J. ; Muir, K. ; Sacco, R. ; Shuaib, A. ; Teal, P. ; Wahlgren, N. G. ; Warach, S. ; Weimar, C. / Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery. In: International Journal of Stroke. 2014 ; Vol. 9, No. 6. pp. 755-758.
@article{af30291d8bb44d6eb48d3c24b0c74591,
title = "Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery",
abstract = "Background: Clinical trials for acute ischemic stroke treatment require large numbers of participants and are expensive to conduct. Methods that enhance statistical power are therefore desirable. Aims: We explored whether this can be achieved by a measure incorporating both early and late measures of outcome (e.g. seven-day NIH Stroke Scale combined with 90-day modified Rankin scale). Methods: We analyzed sensitivity to treatment effect, using proportional odds logistic regression for ordinal scales and generalized estimating equation method for global outcomes, with all analyses adjusted for baseline severity and age. We ran simulations to assess relations between sample size and power for ordinal scales and corresponding global outcomes. We used R version 2·12·1 (R Development Core Team. R Foundation for Statistical Computing, Vienna, Austria) for simulations and SAS 9·2 (SAS Institute Inc., Cary, NC, USA) for all other analyses. Results: Each scale considered for combination was sensitive to treatment effect in isolation. The mRS90 and NIHSS90 had adjusted odds ratio of 1·56 and 1·62, respectively. Adjusted odds ratio for global outcomes of the combination of mRS90 with NIHSS7 and NIHSS90 with NIHSS7 were 1·69 and 1·73, respectively. The smallest sample sizes required to generate statistical power ≥80{\%} for mRS90, NIHSS7, and global outcomes of mRS90 and NIHSS7 combined and NIHSS90 and NIHSS7 combined were 500, 490, 400, and 380, respectively. Discussion: When data concerning both early and late outcomes are combined into a global measure, there is increased sensitivity to treatment effect compared with solitary ordinal scales. This delivers a 20{\%} reduction in required sample size at 80{\%} power. Combining early with late outcomes merits further consideration.",
author = "Goldie, {Fraser C.} and Fulton, {Rachael L.} and Jesse Dawson and Erich Bluhmki and Lees, {Kennedy R.} and Andrei Alexandrov and Bath, {P. W.} and E. Bluhmki and L. Claesson and J. Curram and Davis, {S. M.} and G. Donnan and Diener, {H. C.} and M. Fisher and B. Gregson and J. Grotta and W. Hacke and Hennerici, {M. G.} and M. Hommel and M. Kaste and P. Lyden and J. Marler and K. Muir and R. Sacco and A. Shuaib and P. Teal and Wahlgren, {N. G.} and S. Warach and C. Weimar",
year = "2014",
month = "8",
day = "1",
doi = "10.1111/ijs.12131",
language = "English (US)",
volume = "9",
pages = "755--758",
journal = "International Journal of Stroke",
issn = "1747-4930",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Exploration of time-course combinations of outcome scales for use in a global test of stroke recovery

AU - Goldie, Fraser C.

AU - Fulton, Rachael L.

AU - Dawson, Jesse

AU - Bluhmki, Erich

AU - Lees, Kennedy R.

AU - Alexandrov, Andrei

AU - Bath, P. W.

AU - Bluhmki, E.

AU - Claesson, L.

AU - Curram, J.

AU - Davis, S. M.

AU - Donnan, G.

AU - Diener, H. C.

AU - Fisher, M.

AU - Gregson, B.

AU - Grotta, J.

AU - Hacke, W.

AU - Hennerici, M. G.

AU - Hommel, M.

AU - Kaste, M.

AU - Lyden, P.

AU - Marler, J.

AU - Muir, K.

AU - Sacco, R.

AU - Shuaib, A.

AU - Teal, P.

AU - Wahlgren, N. G.

AU - Warach, S.

AU - Weimar, C.

PY - 2014/8/1

Y1 - 2014/8/1

N2 - Background: Clinical trials for acute ischemic stroke treatment require large numbers of participants and are expensive to conduct. Methods that enhance statistical power are therefore desirable. Aims: We explored whether this can be achieved by a measure incorporating both early and late measures of outcome (e.g. seven-day NIH Stroke Scale combined with 90-day modified Rankin scale). Methods: We analyzed sensitivity to treatment effect, using proportional odds logistic regression for ordinal scales and generalized estimating equation method for global outcomes, with all analyses adjusted for baseline severity and age. We ran simulations to assess relations between sample size and power for ordinal scales and corresponding global outcomes. We used R version 2·12·1 (R Development Core Team. R Foundation for Statistical Computing, Vienna, Austria) for simulations and SAS 9·2 (SAS Institute Inc., Cary, NC, USA) for all other analyses. Results: Each scale considered for combination was sensitive to treatment effect in isolation. The mRS90 and NIHSS90 had adjusted odds ratio of 1·56 and 1·62, respectively. Adjusted odds ratio for global outcomes of the combination of mRS90 with NIHSS7 and NIHSS90 with NIHSS7 were 1·69 and 1·73, respectively. The smallest sample sizes required to generate statistical power ≥80% for mRS90, NIHSS7, and global outcomes of mRS90 and NIHSS7 combined and NIHSS90 and NIHSS7 combined were 500, 490, 400, and 380, respectively. Discussion: When data concerning both early and late outcomes are combined into a global measure, there is increased sensitivity to treatment effect compared with solitary ordinal scales. This delivers a 20% reduction in required sample size at 80% power. Combining early with late outcomes merits further consideration.

AB - Background: Clinical trials for acute ischemic stroke treatment require large numbers of participants and are expensive to conduct. Methods that enhance statistical power are therefore desirable. Aims: We explored whether this can be achieved by a measure incorporating both early and late measures of outcome (e.g. seven-day NIH Stroke Scale combined with 90-day modified Rankin scale). Methods: We analyzed sensitivity to treatment effect, using proportional odds logistic regression for ordinal scales and generalized estimating equation method for global outcomes, with all analyses adjusted for baseline severity and age. We ran simulations to assess relations between sample size and power for ordinal scales and corresponding global outcomes. We used R version 2·12·1 (R Development Core Team. R Foundation for Statistical Computing, Vienna, Austria) for simulations and SAS 9·2 (SAS Institute Inc., Cary, NC, USA) for all other analyses. Results: Each scale considered for combination was sensitive to treatment effect in isolation. The mRS90 and NIHSS90 had adjusted odds ratio of 1·56 and 1·62, respectively. Adjusted odds ratio for global outcomes of the combination of mRS90 with NIHSS7 and NIHSS90 with NIHSS7 were 1·69 and 1·73, respectively. The smallest sample sizes required to generate statistical power ≥80% for mRS90, NIHSS7, and global outcomes of mRS90 and NIHSS7 combined and NIHSS90 and NIHSS7 combined were 500, 490, 400, and 380, respectively. Discussion: When data concerning both early and late outcomes are combined into a global measure, there is increased sensitivity to treatment effect compared with solitary ordinal scales. This delivers a 20% reduction in required sample size at 80% power. Combining early with late outcomes merits further consideration.

UR - http://www.scopus.com/inward/record.url?scp=84904614795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904614795&partnerID=8YFLogxK

U2 - 10.1111/ijs.12131

DO - 10.1111/ijs.12131

M3 - Article

VL - 9

SP - 755

EP - 758

JO - International Journal of Stroke

JF - International Journal of Stroke

SN - 1747-4930

IS - 6

ER -